Versant Venture Capital IV, L.P. Insider Trading $CRSP CRISPR Therapeutics AG
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital IV, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital IV, L.P.. Versant Venture Capital IV, L.P. is 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in CRISPR Therapeutics AG ($CRSP).
Versant Venture Capital IV, L.P. in CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Versant Venture Capital IV, L.P.: 10% Owner
Holdings: 2,238,979 shares
Current Value: $35,263,919
Latest Transaction: Apr 24 2018
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Versant Venture Capital IV, L.P. in CRISPR Therapeutics AG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | S | 50.66 | 6,821 | 345,552 | 117,173 | 124 K to 117.2 K (-5.50 %) |
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | S | 51.00 | 2,915 | 148,665 | 50,072 | 53 K to 50.1 K (-5.50 %) |
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | S | 51.00 | 2,630 | 134,130 | 45,171 | 47.8 K to 45.2 K (-5.50 %) |
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | S | 50.66 | 89,628 | 4,540,554 | 1,539,576 | 1.6 M to 1.5 M (-5.50 %) |
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 92,918 | 0 | 0 | 92.9 K to 0 (-100.00 %) |
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 0.00 | 92,918 | 0 | 92,918 | 0 to 92.9 K |
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 2,947 | 0 | 13,277 | 16.2 K to 13.3 K (-18.16 %) |
| Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 497,053 | 0 | 2,238,979 | 2.7 M to 2.2 M (-18.17 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 1,240 | 0 | 0 | 1.2 K to 0 (-100.00 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 0.00 | 1,240 | 0 | 1,240 | 0 to 1.2 K |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 17,283 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 0.00 | 17,283 | 0 | 17,283 | 0 to 17.3 K |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 292,529 | 0 | 0 | 292.5 K to 0 (-100.00 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Buy | J | 0.00 | 292,529 | 0 | 292,529 | 0 to 292.5 K |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 26,491 | 0 | 52,987 | 79.5 K to 53 K (-33.33 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 61,993 | 0 | 123,994 | 186 K to 124 K (-33.33 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 23,899 | 0 | 47,801 | 71.7 K to 47.8 K (-33.33 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 814,599 | 0 | 1,629,204 | 2.4 M to 1.6 M (-33.33 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 8,110 | 0 | 16,224 | 24.3 K to 16.2 K (-33.33 %) |
| Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Sell | J | 0.00 | 1,368,013 | 0 | 2,736,032 | 4.1 M to 2.7 M (-33.33 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Grant | A | 14.00 | 4,583 | 64,162 | 185,987 | 181.4 K to 186 K (+2.53 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Grant | A | 14.00 | 60,219 | 843,066 | 2,443,803 | 2.4 M to 2.4 M (+2.53 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Grant | A | 14.00 | 602 | 8,428 | 24,334 | 23.7 K to 24.3 K (+2.54 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital IV, L. ... | 10% Owner | Grant | A | 14.00 | 95,596 | 1,338,344 | 4,104,045 | 4 M to 4.1 M (+2.38 %) |
Page: 1